Pilot Study of Vietnamese Self-Help Plus Stress Management for Breast and Gynecologic Cancer Patients in Viet Nam
Led by Boston University · Updated on 2025-11-17
285
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Vietnamese Self Help Plus vSH stress management program for women with breast and gynecologic cancers in Viet Nam. Psychological distress is common but often overlooked in these patients due to clinical workload. This study is a two-arm, single-blind randomized controlled trial comparing the vSH intervention to enhanced usual care, aiming to pilot the intervention and assess its potential effectiveness and feasibility.
Participants are randomly assigned to either the vSH intervention group or the enhanced usual care group. The vSH program involves four 75-minute sessions teaching core stress management skills, led by healthcare workers and peer cancer survivors. Both groups receive an illustrated guide called Doing What Matters in Times of Stress. Participants attend an in-person information session to provide consent and receive their assigned intervention.
Participants complete surveys at baseline, 1-2 weeks post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, quality of life, and cancer coping. Qualitative interviews and focus groups are conducted with participants, caregivers, healthcare workers, and facilitators to evaluate acceptability and feasibility. The total study duration extends through 2026, with assessments occurring by phone after the initial session.
CONDITIONS
Brief Title
Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam
Research Team
P
Phuongthao Le, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Fogarty International Center of the National Institute of Health
Collaborating Sponsor
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
Aged 18 years or older
Clinician-confirmed diagnosis within the past 12 months of first-time breast and/or gynecologic cancer (stages I-III)
Currently receiving or will receive treatment with curative intent
Score less than 8 on the National Comprehensive Cancer Network Distress Thermometer, indicating low to moderate distress
Score less than 15 on the Patient Health Questionnaire-9, indicating low to moderate depression levels
You will not qualify if you...
Selected '2 Several days' or '3 Almost everyday' on PHQ-9 item #9, indicating imminent suicide risk
Severe chronic diseases such as coronary heart disease, COPD, or chronic renal failure, as determined by clinician or study investigator
Risk for psychosis, mania, or alcohol abuse based on screening questions
Unable to attend intervention activities at the hospital during the intervention period
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 4 weeks
Participants attend four 75-minute stress management sessions and receive an illustrated guide to help cope with stress.
4 sessions during the treatment period
Follow-up
Duration - Up to 3 months after treatment
Participants are followed to assess changes in depression, anxiety, and quality of life after the intervention.
2 visits at 1 month and 3 months post-treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Studying Key Non-coding RNAs and Their Interaction With Chromatin Remodeling in Breast Cancer Patients
Comparing 18F-FDG and 68Ga-FAPI-46 PET Scans in Women With ER-positive Breast Cancer
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Study of Using 3D-Printed Custom Devices for High-Dose Radiation Treatment in Gynaecological Cancer
Observational Study Comparing 3D and 2D Echocardiography for Early Heart Damage Detection in Patients Receiving Anthracyclines and HER2-Targeted Cancer Therapies
Study Comparing 3D-Printed Biodegradable Breast Implants, Traditional Breast-Conserving Surgery, and Silicone Implant Reconstruction for Breast Cancer Patients
Using 3D Ultrasound to Guide Needle Placement in Brachytherapy for Advanced or Recurrent Gynecologic Cancers
Ultrahypofractionated 5-Session Whole Breast Radiotherapy with Boost versus Standard 15-Session Radiotherapy for Breast Cancer Patients with Unfavorable Characteristics
Phase II Study Comparing 5-Day vs. 9-Day Whole Breast Radiotherapy with Boost in Early-stage Breast Cancer
Evaluating 68Ga-FAPI PETCT for Checking Axillary Lymph Node Status After Neoadjuvant Therapy in Women with Breast Cancer
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Pilot randomised controlled trial of the self-help plus stress management intervention among patients with breast and gynaecological cancer in Viet Nam: a study protocol.
PhuongThao D Le, Ngoc Bao Nguyen, Anh Thu Thi Dang...